Clinical Trials in Morrow, Georgia
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Atopic Keratoconjunctivitis
Dompé Farmaceutici S.p.A138 enrolled19 locationsNCT07395232
Recruiting
Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline960 enrolled159 locationsNCT06961214
Recruiting
Phase 2
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Glaucoma
Bausch & Lomb Incorporated228 enrolled14 locationsNCT07168902
Recruiting
Phase 3
A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
Dry-Eye Disease
AbbVie250 enrolled20 locationsNCT07284381
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
Dry-Eye Disease
Bausch & Lomb Incorporated423 enrolled32 locationsNCT07128628
Recruiting
Phase 2
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).
Dry-Eye Disease
Instituto Grifols, S.A.100 enrolled10 locationsNCT07264517
Recruiting
Phase 1
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Open Angle GlaucomaOcular Hypertension
Amneal Pharmaceuticals, LLC240 enrolled4 locationsNCT06267274
Recruiting
Phase 3
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Ocular HypertensionGlaucoma, Open-Angle
Amneal Pharmaceuticals, LLC168 enrolled9 locationsNCT05401357